Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-01 Sale | 2024-05-02 9:07 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) | View |
2024-04-01 Sale | 2024-04-03 6:55 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $24.38 | $121,913 | 323,306 (Indirect Direct) | View |
2024-03-13 Sale | 2024-03-15 4:42 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 651 | $28.33 | $18,443 | 328,306 (Indirect Direct) | View |
2023-12-27 Sale | 2023-12-29 8:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $24 | $129,936 | 288,195 (Indirect Direct) | View |
2023-12-14 Sale | 2023-12-18 8:39 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 543 | $20.76 | $11,273 | 245,131 (Indirect Direct) | View |
2023-11-17 Sale | 2023-11-21 5:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 30,000 | $14.68 | $440,259 | 213,177 (Indirect Direct) | View |
2023-10-02 Sale | 2023-10-04 8:33 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $51.1 | $25,039 | 329,908 (Indirect Direct) | View |
2023-09-13 Sale | 2023-09-25 8:28 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 562 | $50.34 | $28,291 | 243,177 (Indirect Direct) | View |
2023-06-13 Sale | 2023-06-15 9:35 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 538 | $55.16 | $29,676 | 243,739 (Indirect Direct) | View |
2023-01-03 Sale | 2023-01-05 5:56 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 8,777 | $54.64 | $479,560 | 328,232 (Indirect Direct) | View |
2022-12-27 Sale | 2022-12-28 6:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $49.57 | $619,609 | 383,025 (Indirect Direct) | View |
2022-10-25 Sale | 2022-10-27 9:25 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $44.72 | $558,944 | 283,510 (Indirect Direct) | View |
2021-11-03 Sale | 2021-11-05 4:17 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 25,000 | $24.28 | $607,123 | 195,510 (Indirect Direct) | View |
2021-09-01 Sale | 2021-09-03 4:38 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $24.04 | $300,500 | 220,510 (Indirect Direct) | View |
2021-06-01 Sale | 2021-06-02 4:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,055 | $26.24 | $80,151 | 224,010 (Indirect Direct) | View |
2021-05-03 Sale | 2021-05-04 4:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,055 | $30.56 | $93,361 | 227,065 (Indirect Direct) | View |
2021-04-01 Sale | 2021-04-05 5:15 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,055 | $28.75 | $87,828 | 230,120 (Indirect Direct) | View |
2021-03-01 Sale | 2021-03-02 5:56 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,055 | $30.48 | $93,112 | 233,175 (Indirect Direct) | View |
2021-02-01 Sale | 2021-02-02 4:08 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,055 | $29.24 | $89,321 | 236,230 (Indirect Direct) | View |
2021-01-08 Sale | 2021-01-11 7:54 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 10,000 | $28.12 | $281,200 | 274,581 (Indirect Direct) | View |
2021-01-04 Sale | 2021-01-06 6:48 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,060 | $25.29 | $77,399 | 241,785 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Exercise | 2024-03-05 5:16 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 83,321 | $0 | 328,957 (Direct) | View |
2024-03-01 Exercise | 2024-03-05 5:16 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 83,321 | $0.615 | 328,957 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 8:30 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $0 | 288,195 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 8:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $6.36 | 288,195 (Direct) | View |
2023-12-08 Option Award | 2023-12-12 4:43 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 178,734 | $0 | 391,911 (Direct) | View |
2023-10-02 Exercise | 2023-10-04 8:33 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $0 | 329,908 (Direct) | View |
2023-10-02 Exercise | 2023-10-04 8:33 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $21.1 | 329,908 (Direct) | View |
2023-03-10 Tax Withholding | 2023-03-14 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 634 | $43.47 | 244,277 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 5:56 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 8,777 | $0 | 328,232 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 5:56 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 8,777 | $0.615 | 328,232 (Direct) | View |
2022-12-27 Exercise | 2022-12-28 6:30 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 383,025 (Direct) | View |
2022-12-27 Exercise | 2022-12-28 6:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 722 | $0.615 | 383,025 (Direct) | View |
2022-12-27 Exercise | 2022-12-28 6:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 11,778 | $6.36 | 383,025 (Direct) | View |
2022-12-16 Option Award | 2022-12-20 7:49 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 29,073 | $0 | 87,221 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 8:30 pm | N/A 2032-12-08 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 105,574 | $0 | 328,828 (Direct) | View |
2022-10-25 Exercise | 2022-10-27 9:25 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 283,510 (Direct) | View |
2022-10-25 Exercise | 2022-10-27 9:25 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $6.36 | 283,510 (Direct) | View |
2022-09-09 Option Award | 2022-09-13 9:16 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 58,148 | $0 | 87,222 (Direct) | View |
2022-01-07 Exercise | 2022-01-11 4:40 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 27,744 | $0 | 316,074 (Direct) | View |
2022-01-07 Exercise | 2022-01-11 4:40 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 27,744 | $0.615 | 316,074 (Direct) | View |
2021-12-08 Option Award | 2021-12-10 5:06 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 87,221 | $0 | 87,221 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 9,000 | $0 | 259,306 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 9,000 | $0.615 | 259,306 (Direct) | View |
2021-01-07 Exercise | 2021-01-11 7:54 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 7,500 | $0 | 274,581 (Direct) | View |
2021-01-07 Exercise | 2021-01-11 7:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 7,500 | $0.615 | 274,581 (Direct) | View |
2020-06-30 Option Award | 2020-12-09 8:53 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 1,245 | $17.07 | 322,425 (Direct) | View |
2020-12-08 Option Award | 2020-12-09 8:53 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 77,580 | $0 | 322,425 (Direct) | View |
2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 11,117 | $0 | 380,664 (Direct) | View |
2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 11,117 | $0.615 | 380,664 (Direct) | View |
2020-01-10 Exercise | 2020-01-10 7:39 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 38,907 | $0 | 440,664 (Direct) | View |
2020-01-10 Exercise | 2020-01-10 7:39 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 38,907 | $0.615 | 440,664 (Direct) | View |
2019-12-30 Acquisition | 2019-12-31 4:16 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 667 | $0 | 253,576 (Direct) | View |
2019-12-13 Option Award | 2019-12-13 9:07 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 85,000 | $0 | 85,000 (Direct) | View |
Ownership | 2019-06-19 6:31 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan EVP, Chief Operating Officer | 0 | $0 | 512,753 (Direct) | View |